Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 5;128(15):2126-9.
doi: 10.4103/0366-6999.161403.

Relief Effect of Bevacizumab on Severe Edema Induced by Re-irradiation in Brain Tumor Patients

Ge Shen  1 , Ying-Jie Wang, Yan-Jun Guan, Da-Peng Dong, Gang Yang, Dan Li, Rui-Min Hao, Hui-Ru Sun, Ming Zhou, Kun-Peng Wang, Shi-Xiang Zhou, Qin-Wen Wang, Shi-Kai Wu, Yan-Jun Zeng
Affiliations

Relief Effect of Bevacizumab on Severe Edema Induced by Re-irradiation in Brain Tumor Patients

Ge Shen et al. Chin Med J (Engl). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Edema volume and bevacizumab treatment time of no. 5 patient.
Figure 2
Figure 2
T2-weighted magnetic resonance imaging of no. 5 patient before bevacizumab treatment (left) and 25 weeks later (right).
See this image and copyright information in PMC

References

    1. Wang Y, Pan L, Sheng X, Mao Y, Yao Y, Wang E, et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res. 2012;17:25. - PMC - PubMed
    1. Williams BJ, Park DM, Sheehan JP. Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery. J Neurosurg. 2012;116:972–7. - PubMed
    1. Williamson R, Kondziolka D, Kanaan H, Lunsford LD, Flickinger JC. Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: A pilot study. Stereotact Funct Neurosurg. 2008;86:359–66. - PubMed
    1. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009;27:4733–40. - PubMed
    1. Yoshida M, Goto M, Kii T, Nishitani H, Kawabe S, Kuwakado S, et al. Retrospective study as first-line chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer. Digestion. 2013;87:59–64. - PubMed